Literature DB >> 17768066

Interlinking interleukin-7.

Christina Kittipatarin1, Annette R Khaled.   

Abstract

The signaling processes that maintain the homeostatic proliferation of peripheral T-cells and result in their self-renewal largely remain to be elucidated. Much focus has been placed on the anti-apoptotic function of the cytokine, interleukin-7 (IL-7), during T-cell development. But a more critical role has been ascribed to IL-7 as a mediator of peripheral T-cell maintenance. The biological effects responsive to IL-7 signaling are transduced through only a few well-known pathways. In this review we will focus on the signals transduced by IL-7 and similar cytokines, examining how proliferative signals originate from cytokine receptors, are amplified and eventually alter gene expression. In this regard we will highlight the crosstalk between pathways that promote survival, drive cell cycle progression and most importantly provide the needed energy to sustain these critical cellular activities. Though this review showcases much of what has been learned about IL-7 proliferative signaling, it also reveals the significant gaps in our knowledge about cytokine signaling in the very relevant context of peripheral T-cell homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17768066      PMCID: PMC2040031          DOI: 10.1016/j.cyto.2007.07.183

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  101 in total

1.  A late, prolonged activation of the phosphatidylinositol 3-kinase pathway is required for T cell proliferation.

Authors:  Ferdinand V Lali; James Crawley; Derek A McCulloch; Brian M J Foxwell
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

2.  Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases.

Authors:  K L Komschlies; T A Gregorio; M E Gruys; T C Back; C R Faltynek; R H Wiltrout
Journal:  J Immunol       Date:  1994-06-15       Impact factor: 5.422

3.  Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members.

Authors:  Qiong Jiang; Wen Qing Li; Robert R Hofmeister; Howard A Young; David R Hodge; Jonathan R Keller; Annette R Khaled; Scott K Durum
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 4.  Jak3 and the pathogenesis of severe combined immunodeficiency.

Authors:  John J O'Shea; Matthew Husa; Denise Li; Sigrun R Hofmann; Wendy Watford; Joseph L Roberts; Rebecca H Buckley; Paul Changelian; Fabio Candotti
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

5.  Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival.

Authors:  Wen Qing Li; Qiong Jiang; Annette R Khaled; Jonathan R Keller; Scott K Durum
Journal:  J Biol Chem       Date:  2004-04-30       Impact factor: 5.157

6.  Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival.

Authors:  Jung-Hyun Park; Qing Yu; Batu Erman; Jacob S Appelbaum; Diego Montoya-Durango; H Leighton Grimes; Alfred Singer
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

7.  Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production.

Authors:  E F Greiner; M Guppy; K Brand
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

8.  Cdc25A is a novel phosphatase functioning early in the cell cycle.

Authors:  S Jinno; K Suto; A Nagata; M Igarashi; Y Kanaoka; H Nojima; H Okayama
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

9.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.

Authors:  J J Peschon; P J Morrissey; K H Grabstein; F J Ramsdell; E Maraskovsky; B C Gliniak; L S Park; S F Ziegler; D E Williams; C B Ware; J D Meyer; B L Davison
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

10.  Transgenic expression of interleukin 7 restores T cell populations in nude mice.

Authors:  B E Rich; P Leder
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  39 in total

1.  Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation.

Authors:  Brian R Lawson; Rosana Gonzalez-Quintial; Theodoros Eleftheriadis; Michael A Farrar; Stephen D Miller; Karsten Sauer; Dorian B McGavern; Dwight H Kono; Roberto Baccala; Argyrios N Theofilopoulos
Journal:  Clin Immunol       Date:  2015-08-25       Impact factor: 3.969

2.  Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapy.

Authors:  Yue Zhang; Lukas W Pfannenstiel; Elzbieta Bolesta; Carolina L Montes; Xiaoyu Zhang; Andrei I Chapoval; Ronald B Gartenhaus; Scott E Strome; Brian R Gastman
Journal:  Clin Cancer Res       Date:  2011-06-28       Impact factor: 12.531

3.  Thymic stromal lymphopoietin and the pathophysiology of atopic disease.

Authors:  Michael M Miazgowicz; Mark B Headley; Ryan P Larson; Steven F Ziegler
Journal:  Expert Rev Clin Immunol       Date:  2009-09-01       Impact factor: 4.473

4.  Interleukin-7 induces recruitment of monocytes/macrophages to endothelium.

Authors:  Rongying Li; Antoni Paul; Kerry W S Ko; Michael Sheldon; Benjamin E Rich; Tomoya Terashima; Carrie Dieker; Shelley Cormier; Lan Li; Elie A Nour; Lawrence Chan; Kazuhiro Oka
Journal:  Eur Heart J       Date:  2011-07-30       Impact factor: 29.983

5.  Serum cytokine analysis in a positive chemoprevention trial: selenium, interleukin-2, and an association with squamous preneoplastic disease.

Authors:  Mark J Roth; Hormuzd A Katki; Wen-Qiang Wei; You-Lin Qiao; Rachel Bagni; Guo-Qing Wang; Denise Whitby; Zhi-Wei Dong; Mitchell H Gail; Paul J Limburg; Carol A Giffen; Philip R Taylor; Sanford M Dawsey
Journal:  Cancer Prev Res (Phila)       Date:  2010-06-29

6.  Interleukin-7 mediates glucose utilization in lymphocytes through transcriptional regulation of the hexokinase II gene.

Authors:  Mounir Chehtane; Annette R Khaled
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-03       Impact factor: 4.249

7.  Cdc25A-driven proliferation regulates CD62L levels and lymphocyte movement in response to interleukin-7.

Authors:  Christina Kittipatarin; Wenqing Li; Scott K Durum; Annette R Khaled
Journal:  Exp Hematol       Date:  2010-09-08       Impact factor: 3.084

8.  PLA2G1B is involved in CD4 anergy and CD4 lymphopenia in HIV-infected patients.

Authors:  Julien Pothlichet; Thierry Rose; Florence Bugault; Louise Jeammet; Annalisa Meola; Ahmed Haouz; Frederick Saul; David Geny; José Alcami; Ezequiel Ruiz-Mateos; Luc Teyton; Gérard Lambeau; Jacques Thèze
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 9.  Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.

Authors:  C M Capitini; A A Chisti; C L Mackall
Journal:  J Intern Med       Date:  2009-08       Impact factor: 8.989

Review 10.  Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival.

Authors:  Nancie J Maciver; Sarah R Jacobs; Heather L Wieman; Jessica A Wofford; Jonathan L Coloff; Jeffrey C Rathmell
Journal:  J Leukoc Biol       Date:  2008-06-24       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.